News

AEON Biopharma Reports Third Quarter 2025 Results, Including Positive ABP-450 Biosimilarity Data and Strategic Positioning for Continued Growth

– FDA Type 2a meeting scheduled for November 19, 2025, to review AEON’s analytical development plan and initial data –...

Electronic Caregiver Announces Breakthrough Results from National Medicare Test of Addison Care(R), Demonstrating Unprecedented Patient Engagement, High Reliability, and Scalability for Nationwide Rollout

error: Content is protected !!